HIT Health In Tech, Inc.
Insurance Agents, Brokers & Service · Nasdaq · SEC CIK 2019505 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $6.59M | $8.06M | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | $4.90M |
| Cost of revenue | $3.52M | $4.13M | $4.26M | $3.38M | $3.35M | $3.00M | $2.66M | $1.11M |
| Gross profit | $3.06M | $3.92M | $4.51M | $4.13M | $5.14M | $6.31M | $5.36M | $3.80M |
| R&D expense | $938,564 | $875,811 | $920,395 | $213,113 | $235,819 | $582,609 | $537,721 | $633,653 |
| SG&A expense | $3.12M | $4.27M | $3.46M | $3.18M | $3.46M | $3.78M | $3.25M | $2.85M |
| Interest expense | $20,000 | — | — | — | — | — | — | $0 |
| Pretax income | -$9.25M | -$3.32M | -$2.07M | -$443,741 | $600,222 | $833,268 | $684,423 | -$110,748 |
| Income tax | -$2.15M | -$809,888 | -$480,069 | -$141,184 | $148,046 | $202,637 | $185,831 | $33,404 |
| Net income | -$7.07M | -$2.51M | -$1.59M | -$302,557 | $452,176 | $630,631 | $498,592 | -$144,152 |
| EPS (basic) | -0.11 | -0.04 | -0.03 | — | 0.01 | 0.01 | 0.01 | — |
| EPS (diluted) | -0.11 | -0.04 | -0.03 | — | 0.01 | 0.01 | 0.01 | — |
| Weighted avg. shares (diluted) | 63.08M | 62.83M | 57.35M | — | 58.77M | 55.63M | 57.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.13M | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M |
| Receivables | $3.18M | $8.55M | $3.74M | $756,288 | $868,628 | $1.28M | $2.11M | $1.65M |
| Current assets | $17.09M | $21.78M | $22.09M | $16.16M | $15.05M | $14.85M | $15.57M | $10.78M |
| Total assets | $28.03M | $29.63M | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | $15.77M |
| Current liabilities | $15.15M | $9.99M | $7.05M | $5.16M | $5.24M | $5.39M | $6.75M | $2.13M |
| Total liabilities | $15.15M | $10.01M | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | $2.60M |
| Shareholders' equity | $12.85M | $19.55M | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.05M | -$2.91M | -$3.32M | $451,211 | $673,973 | $1.48M | $527,353 | -$531,167 |
| Investing cash flow | -$842,164 | -$596,992 | -$362,131 | -$767,708 | -$744,841 | -$909,897 | -$703,475 | -$542,121 |
| Financing cash flow | $5.50M | -$301,083 | $6.34M | -$37,362 | -$43,685 | -$8,250 | -$98,089 | $7.18M |
| Depreciation & amortization | $278,747 | $320,320 | $403,467 | $410,630 | $217,981 | $135,983 | $135,983 | $135,983 |
| Stock-based compensation | $728,571 | $959,320 | $366,562 | $76,733 | $292,552 | $707,963 | $493,171 | — |
Free plan shows the latest 8 periods; Pro shows all 11 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.